Condition
Appetite Regulation
ClinicalTrials.gov condition label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 19 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
19 shownImpact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide TerminationNCT07294950 · 2026-02-01
RECRUITINGThe Impact of a Daily Dietary Supplement on Glycemic Control in Individuals With Overweight or ObesityNCT07837817 · 2026-10-01
NOT_YET_RECRUITINGEffects of Transcutaneous Auricular Vagus Nerve Stimulation on AppetiteNCT07444177 · 2026-01-12
COMPLETEDEfficacy of Satisens® in Reducing Emotional EatingNCT07079046 · 2025-09-15
COMPLETEDTailoring Obesity Treatment TrialNCT06619015 · 2025-04-01
WITHDRAWNEffects of Meal Energy Density on Body Measures and Metabolism in WomenNCT07066618 · 2023-11-15
COMPLETEDEffect of Lower Doses of Colonic Nutrient Supplementation on Appetite Hormones and Food Intake in Obese AdultsNCT07491835 · 2023-10-18
COMPLETEDColonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in ObesityNCT07448519 · 2023-06-13
COMPLETEDEffect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese AdultsNCT06827002 · 2023-03-29
ACTIVE_NOT_RECRUITINGPostprandial Glycemia and Satiety of Meals With Potatoes, With and Without ProteinNCT05610124 · 2023-02-01
UNKNOWNImpact of Sourdough Bread Consumption on Long-term Energy Intake: A Pilot Study of FeasibilityNCT05590611 · 2022-12-01
UNKNOWNONE PATH: Optimizing Nutrition Education for Parents and Teachers for Healthy GrowthNCT03817021 · 2022-07-21
COMPLETEDEffectiveness of a Natural Ingredient on Appetite RegulationNCT04345029 · 2020-01-15
COMPLETEDColonic Propionate, Appetite, and Weight LossNCT03322514 · 2017-03-29
COMPLETEDThe Role of GLP-1 in Satiety Perception in HumansNCT01152333 · 2010-07-01
WITHDRAWNProSat - Long Term Effect of Probiotics on SatietyNCT01240018 · 2009-09-01
COMPLETEDEffect of Oligofructose on Appetite in Overweight SubjectsNCT00912197 · 2009-06-01
COMPLETEDEffects of Time of Sleep Restriction in ObesityNCT01259895 · 2009-02-01
COMPLETEDProSat - Effect of Probiotics on SatietyNCT00826761 · 2009-01-01
COMPLETEDCommon interventions
placeboDIETARY_SUPPLEMENT2probioticDIETARY_SUPPLEMENT2Abrupt cessation of semaglutideDRUG1Ad libitum full-fat French fries with beef meatballsOTHER1Ad libitum full-fat French fries with vegetarian substitute meatballsOTHER1Ad libitum instant mashed potatoes with beef meatballsOTHER1Ad libitum instant mashed potatoes with vegetarian substitute meatballsOTHER1Ad libitum macaroni pasta with beef meatballsOTHER1Ad libitum macaroni pasta with vegetarian substitute meatballsOTHER1Arm 1 (Medium Dose): 250mg DIM and 1050mg Perilla oil in GuardCap™ colon-targeted capsules, activating GPR84 and FFA4 to stimulate PYY and GLP-1 release.DIETARY_SUPPLEMENT1Arm 2 (Low Dose): 125mg DIM and 525mg Perilla oil in GuardCap™ colon-targeted capsules, activating GPR84 and FFA4 to stimulate PYY and GLP-1 release.DIETARY_SUPPLEMENT1Breakfast-Loaded Hypocaloric DietBEHAVIORAL1Child interventionBEHAVIORAL1Cissus quadrangulariaDRUG1Colonic-delivered DIM + Perilla oilDIETARY_SUPPLEMENT1DextrinDRUG1Dichrostachys glomerataDRUG1Dietary Intervention with Brown BreadOTHER1Dietary Intervention with Sourdough BreadOTHER1Dietary supplement consumptionDIETARY_SUPPLEMENT1Dietary Supplement: Colonic-delivered PlaceboDIETARY_SUPPLEMENT1Dinner-Loaded Hypocaloric DietBEHAVIORAL1ECE ProviderBEHAVIORAL1Exendin-(9-39) AcetateDRUG1Gradual dose reduction of semaglutideDRUG1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Imperial College London
2
Queen Mary University of London
2
University of Copenhagen
2
Esbjerg Hospital - University Hospital of Southern Denmark
1
Federal University of São Paulo
1
José Enrique de la Rubia Ortí, Ph
1
KU Leuven
1
Melike Nur Eroğlu
1
Mount Sinai Hospital, Canada
1
Penn State University
1
Seoul National University Hospital
1
Universidad Católica San Antonio de Murcia
1
University of South Alabama
1
University of Toronto
1
University of Washington
1
Trial status mix
COMPLETED12
UNKNOWN2
WITHDRAWN2
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
RECRUITING1
Phase mix
NA15
PHASE22
PHASE32
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.